SERA PROGNOSTICS, INC.

(SERA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/16/2022 05/17/2022 05/18/2022 05/19/2022 05/20/2022 Date
1.7(c) 1.54(c) 1.5(c) 1.53(c) 1.53(c) Last
72 065 147 800 123 960 155 531 125 895 Volume
0.00% -9.41% -2.60% +2.00% 0.00% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 0,57 M - -
Net income 2022 -20,0 M - -
Net cash position 2022 58,0 M - -
P/E ratio 2022 -1,49x
Yield 2022 -
Sales 2023 13,7 M - -
Net income 2023 -47,3 M - -
Net cash position 2023 9,00 M - -
P/E ratio 2023 -1,04x
Yield 2023 -
Capitalization 47,3 M 47,3 M -
EV / Sales 2022 -18,7x
EV / Sales 2023 2,80x
Nbr of Employees 114
Free-Float 69,6%
More Financials
Company
Sera Prognostics, Inc. is a women’s health diagnostic company that is focused on utilizing its proteomics and bioinformatics platform to discover, develop and commercialize clinically impactful biomarker tests, with an initial focus on improving pregnancy outcomes. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers... 
More about the company
Ratings of Sera Prognostics, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about SERA PROGNOSTICS, INC.
05/19Sera Prognostics, Inc. Announces Publication of Data Demonstrating Improved Performance..
CI
05/19Sera prognostics announces publication of data demonstrating improved performance of it..
PR
05/18Sera prognostics presents data demonstrating the health and economic benefit of pretrm®..
PR
05/16Berenberg Bank Adjusts Sera Prognostics' Price Target to $12 From $13, Maintains Buy Ra..
MT
05/10Earnings Flash (SERA) SERA PROGNOSTICS Reports Q1 Revenue $38,000
MT
05/10SERA PROGNOSTICS, INC. Management's Discussion and Analysis of Financial Condition and..
AQ
05/10Sera Prognostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2..
CI
05/10Sera prognostics reports first quarter 2022 financial results
PR
05/05Sera prognostics and newborn foundation partner to reduce risks associated with preterm..
PR
05/02Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 202..
PR
04/27Berenberg Bank Initiates Coverage on Sera Prognostics With Buy Rating, $13 Price Target
MT
04/12SERA PROGNOSTICS, INC. : Change in Directors or Principal Officers, Financial Statements a..
AQ
04/12Sera Prognostics, Inc Appoints Jane F. Barlow as Director to the Board to Serve as Clas..
CI
03/30Oppenheimer Adjusts Sera Prognostics Price Target to $17 From $19, Maintains Outperform..
MT
03/30Citigroup Downgrades Sera Prognostics to Neutral From Buy, Adjusts Price Target to $4 F..
MT
More news
News in other languages on SERA PROGNOSTICS, INC.
05/19Sera Prognostics, Inc. annonce la publication de données démontrant l'amélioration des ..
05/10Earnings Flash (SERA) SERA PROGNOSTICS annonce un revenu de 38 000 $ pour le premier tr..
05/10Sera Prognostics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars ..
04/12Sera Prognostics, Inc. nomme Jane F. Barlow au conseil d'administration en tant qu'admi..
03/29Sera Prognostics réduit sa perte au quatrième trimestre et augmente son chiffre d'affai..
More news
Analyst Recommendations on SERA PROGNOSTICS, INC.
More recommendations
Chart SERA PROGNOSTICS, INC.
Duration : Period :
Sera Prognostics, Inc. Technical Analysis Chart | SERA | US81749D1072 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 1,53 $
Average target price 10,33 $
Spread / Average Target 575%
EPS Revisions
Managers and Directors
Gregory C. Critchfield Chairman, President & Chief Executive Officer
Jay M. Moyes Chief Financial Officer
John J. Boniface Chief Scientific Officer
Thomas J. Garite Vice President-Clinical Sciences
Robert Gardner Harrison Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
SERA PROGNOSTICS, INC.-77.73%47
SGS AG-22.12%18 298
EUROFINS SCIENTIFIC SE-21.42%17 440
SOTERA HEALTH COMPANY-16.09%5 588
CENTRE TESTING INTERNATIONAL GROUP CO. LTD.-22.63%5 218
PONY TESTING CO., LTD.4.59%1 648